Home > Insider Trading > Filing (0001104659-19-065582)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661059	Nextcure Inc.	NXTC	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1202793	Michael Powell	C/O Sofinnova Investments, Inc., 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025	No	No	Yes	No
1245624	James Healy	C/O Sofinnova Investments, Inc., 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025	No	No	Yes	No
1590102	Anand Mehra	C/O Sofinnova Investments, Inc., 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025	No	No	Yes	No
1612133	Sofinnova Venture Partners Ix, L.p.	C/O Sofinnova Investments, Inc., 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025	No	No	Yes	No
1612134	Sofinnova Management Ix, L.l.c.	C/O Sofinnova Investments, Inc., 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-15	150,000	$36.75	2,671,856	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The shares are held directly by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Sofinnova Management IX, L.L.C. ("SM IX") is the general partner of SVP IX and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP IX. Dr. James I. Healy, Michael F. Powell, Ph.D., and Dr. Anand Mehra are the managing members of SM IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP IX. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.